chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient noted blurry vision, tingling hands and anxiety immediately following injection at 548pm. Brought to observation by wheelchair at 600pm, sweaty with dry mouth. Examined by Dr.. Vitals WNL. Pt given and consumed 1 bottle water, began to feel better immediately. Sweating resolved and vision WNL by 610pm. Observed until 620pm. No symptoms. Released.
Information has been received from a physician concerning his 9 year old son with no medical history who on 2/9/96 was vaccinated in the right thigh with the first dose of varicella virus vaccine live (lot # 608582/0410B). There was no concomitant therapy or illness at the time of vaccination. The physician reported that on 4/30/04, his son was diagnosed with chicken pox. The physician noted that it was not a case of breakthrough chicken pox, but was much more severe with his son developing a mild fever and lesions on his trunk and genital area. The patient was treated with Acyclovir and subsequently recovered from the chicken pox. The physician also reported that eight other children in his son's school also developed chicken pox after being vaccinated with varicella virus vaccine live. Additional information is not expected.
FATIGUE; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: UNKNOWN expiry: UNKNOWN) .5 ml, administered on 04-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On MAR-2021, the subject experienced fatigue. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from fatigue. This report was non-serious.
Headache started at 1400 the same day as the vaccine. The next day a raised rash on left hand and right foot appeared as well as tenderness on right arm and right armpit
This case was reported by a pharmacist via call center representative and described the occurrence of lip swelling in a elderly female patient who received SHINGRIX (batch number HG4P3, expiry date 13th July 2020). Concurrent medical conditions included blood pressure. In May 2018, the patient received the 1st dose of SHINGRIX (intramuscular) .5 ml. In May 2018, 1 day after receiving SHINGRIX, the patient experienced lip swelling, injection site itching, angular cheilitis and facial swelling. The patient was treated with BENADRYL. In May 2018, the outcome of the lip swelling, injection site itching, angular cheilitis and facial swelling were recovered/resolved. The reporter considered the lip swelling, injection site itching and facial swelling to be almost certainly related to SHINGRIX. It was unknown if the reporter considered the angular cheilitis to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The pharmacist was administered the vaccine last Monday. The patient had lip swelling that following day of vaccination. The patient took BENADRYL and it resolved. The patient had another flare where the corner of her mouth swelled up and below the lip near her chin had swelling as well on the 3rd day after vaccination. The patient took BENADRYL for each incident but reported that her symptoms were slow to resolve and it took a better part of the day for them to resolve. The patient also reported that her arm at the injection site itched on and off. The patient was symptom free. The only change that the patient reported to the pharmacist was that she increased her blood pressure medication a few weeks ago. No other information available. The patient had not yet reported her symptoms to her doctor.
I felt like I was going to faint so I went up to the team and I said I felt woozy and light headed. They had me sit where they could watch me. Someone took my vitals and my heart rate was irregular. They sent me to the ER. By the time I got to the ER they said my EKG was normal. When I got home I had a really bad head ache and I am subject to migraines. I took a migraine pill. I also threw up, but that happens when I get a migraine. When I took my second shot I took migraine pill and I was ok.
Large lymph node swelling on left side of neck; This is a spontaneous report from a contactable consumer. A patient of unspecified age and gender received bnt162b2 (UNSPECIFIED TRADE NAME, Solution for injection, lot/batch number and expiration date not provided), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced large lymph node swelling on left side of neck after use of product. Shot was in the left. The outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
This spontaneous report was received from a healthcare worker referring to a 6 month old patient of unknown gender. The patients' concurrent conditions and medical histories were not provided. On 30-OCT-2015, the patient was vaccinated with a dose of improperly stored ROTATEQ, orally (dose was unknown, lot # K023532, expiration date 21-JUN-2016). Concomitant medication was not reported. No adverse effects were reported. This is one of several reports from the same source. Additional information has been requested.
The patient received a dose of the vaccine following temperature excursions on unknown dates; No adverse event; This spontaneous report as received from a medical assistant refers to a current 3-month-old patient of unknown gender.  The patient's concurrent conditions, medical history and concomitant medications were not provided.   On an unknown date, the rotavirus vaccine, live, oral, pentavalent (ROTATEQ)  (lot # S013439 with expiration date 03-MAR-2021, lot # S013436 with expiration date 30-JAN-2021, and lot # S006050 with expiration date 12-DEC-2020) underwent a temperature excursion.   Temperature Total Time and LOWEST Temperature BELOW 36°F/2°C (0C) Time frame 7 hours 30 minutes Previous temperature excursion? yes, Total Time and LOWEST Temperature BELOW 36°F/2°C (0C) for 8 hours 30 minutes Was call because of a "data logger"? yes  On an unknown date, the patient was vaccinated with rotavirus vaccine, live, oral, pentavalent (ROTATEQ) at a dose of 2 ml (route not provided) as prophylaxis. No adverse events were reported.  This is one of several reports received from the same reporter  This spontaneous report as received from a other health professional refers to a patient of unknown age.    On an unknown date the patient was vaccinated with rotavirus vaccine, live, oral, pentavalent (ROTATEQ) lot # S006050, 2 milliliter for prophylaxis.       On an unknown date the patient experienced product storage error and no adverse event.    The outcome of product storage error and no adverse event is unknown.   The reporter considered product storage error and no adverse event to be not assessed to Rotavirus Vaccine, Live, Oral, Pentavalent(ROTATEQ).     {Additional information has been requested. / Additional information is not expected.}; Sender's Comments:  US-009507513-2005USA003382: US-009507513-2005USA004545: US-009507513-2005USA004950: US-009507513-2005USA004951: US-009507513-2005USA004952: US-009507513-2005USA004953: US-009507513-2005USA004954: US-009507513-2005USA004955: US-009507513-2005USA004956: US-009507513-2005USA004957: US-009507513-2005USA004958: US-009507513-2005USA004959: US-009507513-2005USA004960: US-009507513-2005USA004961: US-009507513-2005USA004962: US-009507513-2005USA004963: US-009507513-2005USA004964: US-009507513-2005USA004965: US-009507513-2005USA004966: US-009507513-2005USA004967: US-009507513-2005USA004968: US-009507513-2005USA004969: US-009507513-2005USA004970: US-009507513-2005USA004971: US-009507513-2005USA004972: US-009507513-2005USA004973: US-009507513-2005USA004974: US-009507513-2005USA004975: US-009507513-2005USA004976: US-009507513-2005USA004977: US-009507513-2005USA004978: US-009507513-2005USA004979: US-009507513-2005USA004980: US-009507513-2005USA004981: US-009507513-2005USA004982: US-009507513-2005USA004983: US-009507513-2005USA004984: US-009507513-2005USA004985: US-009507513-2005USA004986: US-009507513-2005USA004987: US-009507513-2005USA004988: US-009507513-2005USA004989: US-009507513-2005USA004990: US-009507513-2005USA004991: US-009507513-2005USA004993:
PER PATIENT SHE HAS BEEN HAVING CHILLS, FEELING FEVERISH BUT NO ACTUAL RAISED TEMPERATURE, DIARRHEA, HIGH BLOOD PRESSURE .
L arm - deltoid region with redness, warmth and itching per patient, upon return to office on 1/22/2008, where ADACEL was given.
Three days after the shot I had encountered an instance of maintaining an Erection during intercourse. This is the first time ever experiencing such issue. It got much worse in the following weeks. Issue persisted until late April after which I am totally fine.
cardiac arrest; Initial information received from on 27-Jan-2022 regarding an unsolicited valid Social Media serious case received from a consumer/non-hcp (non health care professional).  This case involves an unknown age and unknown gender patient who experienced cardiac arrest while receiving vaccine INFLUENZA VACCINE.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On an unknown date, the patient received a  dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number , strength, formulation and expiry date was unknown) via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date the patient developed a serious cardiac arrest (unknown latency) following the administration of INFLUENZA VACCINE. This event was assessed as medically significant.  Action taken with INFLUENZA VACCINE (INFLUENZA VACCINE) was not applicable.  It was not reported if the patient received a corrective treatment for the event (cardiac arrest).  At time of reporting, the outcome was Unknown for the event cardiac arrest.; Sender's Comments: Sanofi Company Comment on 06-Feb-2022: This case involves an unknown age and unknown gender patient who experienced cardiac arrest while receiving vaccine INFLUENZA VACCINE. Temporal relationship is unknown. Further information regarding medical history, concurrent condition during vaccination, previous vaccination, concomitant medication and tolerance, allergic history, laboratory investigations excluding alternative etiologies for the reported event are needed to fully assess this case. Based upon the reported information, the role of the individual suspect vaccine cannot be assessed.
Information has been received from a nurse concerning a 24 years old female who was vaccinated with the first dose of GARDASIL. Concomitant therapy included hormonal contraceptives (unspecified). The patient developed a rash around the site of injection the day after receiving GARDASIL. Also, the patient developed a generalized rash two weeks after vaccination. At the time of the report, the patient had not recovered. The patient sought medical attention via telephone. Additional information has been requested.
The night of 10/18 the Employee noticed reddening of her injection site. On 10/21 the employee reported symptoms of increased size of the reddening of her arm, arm tenderness/pain, low grade fever, general malaise. Reaction being reported to proper triage.
This case was reported by a consumer and described the occurrence of whole body itching in a subject of unspecified age and gender who was vaccinated with ENGERIX B (GlaxoSmithKline). A physician or other health care professional has not verified this report. On 7 June 2012 the subject received 2nd dose of ENGERIX B (unknown). Within a day after vaccination with ENGERIX B, the subject experienced severe, uncontrollable itching over her entire body. The itching continued despite taking multiple antihistamines, prednisone and applications of various topical agents. "Pruritus is my only symptom. Nothing else changed or was added to my system." At the time of reporting the whole body itching and itching were unresolved.
A report has been received from a Health Professional concerning a 65 year old, male subject, who had been receiving FLUMIST QUADRIVALENT (intranasal). FLUMIST QUADRIVALENT (intranasal) started on 01-Oct-2014. It was reported that the FLUMIST QUADRIVALENT was administered to four patients over the age of 49 which started on 01-Oct-2014. The outcome of the event of inadvertent administration of FLUMIST QUADRIVALENT to patient over 49 years of age is unknown. The report was considered to be non-serious.
pt stated that both hands and arms started itching.  She took Zyrtec and Allegra on them which did not help.  She developed a rash on the palms of her hands, bottoms of her feet, upper right arm and right thigh.  She contacted her doctor and was told to use Benadryl.  This helped very little.  Pt went to the doctor where she was given a steroid shot and prescribed a steroid cream to use for 1 week.  She was not advised not to get the 2nd dose.   She had an annual appt to see her Dermatologist and they drained a cyst that had developed on her back.  The doctor thinks this developed from the infection from the rash her body was fighting but was advised to get the 2nd dose.  The skins on her hands and feet peeled off so she went back to her PCP.  She was referred to an allergist and prescribed her more steroid cream.  Pt went to allergist which did a scratch test for 75 different foods and a blood test for blueberries (these were eaten about the time the rash appeared) which were both negative. Pt took the 2nd dose of the covid vax where she only had a little itching and a minor rash.  She applied triamcinolone acetonide which helped.  Pt says she no longer has any of these symptoms.
Tightness and pain across the chest, extreme lethargy and lack of energy.  Went from running 127 miles in an ultra marathon in March, 21 to barely being able to climb a set of stairs in October, 21.
AT AN OFFSITE CLINIC, SHE HAD 3 SEIZURES AFTER RECEIVING HER 1ST COVID VACCINE. 911 WAS CALLED AND RESPONDED. VITALS LISTED BELOW. EMS SAID SHE WAS DEHYDRATED AND STARTED AN IV OF NORMAL SALINE, THEN SHE HAD A 4TH SEIZURE.  SHE WAS TRANSPORTED TO RECEIVING HOSPITAL. SHE HAD ORIGINALLY STATED ON HER CONSENT SHE DIDN'T HAVE ANY HEALTH CONDITIONS. HER HUSBAND EXPLAINED WHAT SHE HAS. AND SHE SAID SHE HAD TAKEN HER MEDICATIONS THAT DAY AND HER HUSBAND SAID SHE HADN'T TAKEN HER MEDICATION THAT DAY.
Patient calls clinic at approximately 9:10am on 6/7/2023 with complains of: Swollen upper arm (3 inches larger than her right), redness, pain at the site of injection (LUA).  Patient reports that she took Tylenol last night at bed time and Benadryl this morning with no change in symptoms.  Discussed possibility of her stopping by the clinic to be assessed.  Patient stated she could stop by and at that time states "My chest hurts".  When asked how long her chest has been hurting patient replies since last night and that her lungs feel tight.   Patient is advised to seek emergency medical care immediately.   Patient states she is leaving work and going to the nearest ER.
This spontaneous report as received from a pharmacist refers to a 66 year old male patient with degenerative arthritis and unspecified cardiac condition. The patient had no drug reactions/allergies. On 24-JUL-2014, the patient was vaccinated with a dose of ZOSTAVAX (lot # K000329, expiration date 06-MAR-2015), subcutaneous (dose and strength not reported) which was about one month after he had an active case of the shingles. Concomitant medications included unknown number of unspecified medications. The pharmacist reported that the patient stated that on an unspecified date (in approximately July 2014) after he received the ZOSTAVAX (almost immediately), he began to feel weak, achey and sore. The patient additionally stated that he experienced pain and tingling in the spots in which he had the active case of the shingles only one month prior on his side and his face. The pharmacist reported that the patient saw his primary care physician who ordered an X-ray in which showed his preexisting degenerative arthritis in his joints, therefore made the diagnosis of a flare up of his arthritis. The pharmacist thought that this patient was actually experienced these symptoms from the ZOSTAVAX and it might be another zoster out break brought on by the ZOSTAVAX. Additional information has been requested.
I have had 3 Pfizer COVID shots; I may have experienced a little pain in my shoulders; Extra dose administered; This is a spontaneous report from a contactable consumer (patient). A 77-year-old male patient (age at vaccination: 77 years) received third dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number: FA7485 and expiry date were not reported), via an unspecified route of administration, on 18Aug2021, as a single dose for COVID-19 immunization, second dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number and expiry date were not reported), via an unspecified route of administration, on 23Mar2021, as a single dose for COVID-19 immunization and first dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number and expiry date were not reported), via an unspecified route of administration, on 02Mar2021, as a single dose for COVID-19 immunization. The patient's medical history included idiopathic pulmonary fibrosis in 2012 and polymyalgia rhuematica in 2018. Concomitant medication included prednisone acetate (PREDNISONE). The patient reported that he had 3 Pfizer COVID shots. 1st on 02Mar2021, 2nd on 23Mar2021 and 3rd ('booster') on 18Aug2021. The length of time between the 1st and 3rd was just under 5 months. He was immunocompromised in that he has been on Prednisone for about 3 years. His current dosage was 10 mg per day. The patient asked was there any difference in the shots that he had received and were all 3 the same or was each shot different in some way. If there was a difference in any of those shots, would you please explain. He had no difficulty or side affects with any of the shots (he might have experienced a little pain in his shoulders with the 3rd shot). Outcome of the events was unknown.  Follow-up attempts are completed. No further information is expected.
Tested COVID+ on 7/4/21.O2 demands gradually increased until intubation and mechanical ventilation required 7/18/2021. Developed ARDS, HCAP and shock. Transitioned to CMO and expired 7/29/2021.
Initial report was received on 28 March 2013 from a consumer, who is also the patient. A male patient who had no illness at the time of vaccination and no known allergies had received on 09 January 2013 an intradermal injection of FLUZONE INTRADERMAL (lot number and site of administration not reported) and an unspecified amount of time later, developed "type B" flu. No further information was available at the time of the report. The patient's outcome was recovered. Documents held by sender: none.
COVID 19; COVID 19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 78-year-old male patient received BNT162b2 (BNT162B2), on 07Apr2022 at 11:00 as dose number unknown, single (Lot number: FK9893) at the age of 78 years, in left arm for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "recovering" and all described as "COVID 19". Therapeutic measures were taken as a result of drug ineffective, covid-19 Paxlovid from 11Jul2022 to 15Jul2022. Recurrence of cough, sore throat, general malaise from 21Jul2022.
Within 12 hours after the injection I was feeling a little dizzy and very warm. I went home and checked my temperature before getting into bed and saw it was 103. I had chills, pain in my arm, very hot to the touch, and could not sleep through the night with the amount of pain and discomfort I was in.
Patient began having redness and swelling on 7-12-07 in PM after administered that day in face, eyes, and both legs. Taken to ER on Saturday 7-14-07 given Benadryl, Amoxiclav and Tylenol. Cellulitis on right leg. Has reactions to bug bites. Very sensitive skin.
small fever; severe headache; it was like a migraine; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (severe headache), MIGRAINE (it was like a migraine) and PYREXIA (small fever) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, the patient experienced HEADACHE (severe headache) and MIGRAINE (it was like a migraine). On an unknown date, the patient experienced PYREXIA (small fever). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, HEADACHE (severe headache), MIGRAINE (it was like a migraine) and PYREXIA (small fever) outcome was unknown.            Patient reported that he received Second shot on 25Feb2021. Lot number is not available. She got a severe headache after the second dose. It started right away. It was almost like a migraine. Lasted for one day and a half (the worst part) It took three days to go away completely. She also had a small fever but that didn't bother her as much.   This case was linked to US-MODERNATX, INC.-MOD-2021-031764 (E2B Linked Report). This case was linked to MOD21-042855 (Patient Link).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-031764:CROSSLINKED CASE TO WIFE: MOD21-042859
Shot administered on evening of 11/01/4. No problems noted. On evening of 11/02/04, a red area with diameter of approximately 2" was present. (no fever associated with ). Pt was brought to hospital to have Peds look at site. The diameter of the red area on 11/03/04 is approximately 4". Mother will monitor.
Pt received MMR on 3/23/04. He reports that rash on his right lower abdomen (approx. 3" x 1") and small area on mid-back appeared suddenly on 3/27/04. Reports rash does not itch. Pt to go see MD today or tomorrow.
Chills: 13 - 37 hours after injection Sweating: 20 - 37 hours after injection Leg muscle pain: 23 - 26 hours after injection Hard itchy red lump appeared below injection site
Initial report was received from a health care professional through the local affiliate on 21 August 2012 under local reference number BR2012-427. A female patient (age not reported) had received an injection of INFLUENZA VACCINE (manufacturer, lot number, route and site not reported) on 16 May 2012 and an unspecified amount of time later presented influenza A/H1N1 that was confirmed with laboratory tests performed on 16 July 2012. Universal detection of swine-origin influenza A and specific detection of influenza pandemic strain A/H1N1 were positive except for Influenza A seasonal. No additional information was provided. The patient's outcome was unknown. Documents held by sender: None.
pt vomited x3 hr p/vax;then had poor muscle tone & a possible febrile sz;temp was not taken @ home & no APAP ;
Site: Redness at Injection Site-Mild, Site: Swelling at Injection Site-Mild, Systemic: Allergic: Rash Generalized-Medium, Systemic: Chills-Mild, Additional Details: Patient states lump and redness at injection site to start, chills, then rash on arms, stomach, back and legs, not itchy.  History of Psoriasis.  Pt presented to pharmacy 7/30/21 and was advised to see physician.  Patient went to urgent care, was given course of prednisone.  At pick up, I advised pt to seek advice from primary md or dermatologist, and to discuss future vaccines with them.  (pt recently moved to area and will need to establish with new primary md)